Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_1
3
30%
Ph phase_4
1
10%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Recruiting2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (33.3%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

recruiting220%
withdrawn110%
completed660%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10